References
- Gurwith M. J., Brunton J. L., Lank B. A., et al. A prospective controlled investigation of prophylactic trimethoprim/sulfamethoxazole in hospitalized granulocytopenic patients. Am J Med 1979; 66: 248–257
- Pizzo P. A., Robichaud K. J., Gill F. A., Witebsky F. G. Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia. Am J Med 1982; 72: 101–111
- Bodey G. P. Candidiasis in cancer patients. Am J Med 1984; 77: 13–19
- Ezdinli E. Z., O'Sullivan D. D., Wasser L. P., et al. Oral amphotericin for candidiasis in patients with hematologic neoplasms. JAMA 1979; 242: 258–261
- Degregorio M. W., Lee W. M. F., Ries C. A. Candida infections in patients with acute leukemia: Ineffectiveness of nystatin prophylaxis and relationship between oropharyngeal and systemic candidiasis. Cancer 1982; 50: 2780–2784
- Borelli D., Fuentes J., Leiderman E., et al. Ketoconazole, an oral antifungal: Laboratory and clinical assessment of imidazole drugs. Postgrad Med J 1979; 55: 657–661
- Borgers M. Mechanism of action of antifungal drugs, with specific reference to the imidazole derivatives. Rev Infect Dis 1980; 2: 520–534
- Cohen J. Antifungal chemotherapy. Lancet 1982; 2: 532–537
- Jones P. G., Kauffman C. A., McAuliffe L. S., et al. Efficacy of ketoconazole v nystatin in prevention of fungal infections in neutropenic patients. Arch Intern Med 1984; 144: 549–551
- Schimpff S. C., Greene W. H., Young V. M., et al. Infection prevention in acute nonlymphocytic leukemia (laminar air flow room reverse isolation with oral, nonabsorbable antibiotic prophylaxis). Ann Intern Med 1975; 82: 351–358
- Singer C., Kaplan M. H., Armstrong. Bacteremia and fungemia complicating neoplastic disease. A study of 364 cases. Am J Med 1977; 62: 731–743
- Gurwith M. J., Brunton J. L., Lank B. A., et al. Granulocyotpenia in hospitalized patients. I. Prognostic factors and etiology of fever. Am J Med 1978; 64: 121–126
- Gold J. W. M. Opportunistic fungal infections in patients with neoplastic disease. Am J Med 1984; 76: 458–463
- Bodey G. P. Antibiotics in patients with neutropenia. Arch Intern Med 1984; 144: 1845–1851
- Meunier-Carpentier F., Kiehn T. E., Armstrong D. Fungemia in the immunocompromised host: Changing patterns, antigenemia, high mortality. Am J Med 1981; 71: 363–370
- Maksymiuk A. W., Thongprasert S., Hopfer R., et al. Systemic candidiasis in cancer patients. Am J Med 1984; 77: 20–27
- Hann I. M., Prentice H. G., Corringham R., et al. Ketoconazole versus nystatin plus amphotericin B for fungal prophylaxis in severely immunocompromised patients. Lancet 1982; 1: 826–829
- Hurd D. D., Canafax D. M., Kenyon P. D., et al. Randomized trial of high-dose ketoconazole (KETO) or nystatin (NYS) as fungal prophylaxis during intensive chemotherapy. Proc ASCO 1984; 3: 99